Pieter A van Doorn Selected Research

Immunomodulating Agents

5/2023	Primary SARS-CoV-2 infection in patients with immune-mediated inflammatory diseases: long-term humoral immune responses and effects on disease activity.
1/2017	Immunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy.
6/2013	Immunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy.
11/2010	Immunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pieter A van Doorn Research Topics

Disease

44	Guillain-Barre Syndrome 01/2023 - 04/2003
31	Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) 12/2023 - 06/2005
27	Glycogen Storage Disease Type II (Pompe's Disease) 03/2023 - 06/2003
13	Polyneuropathies (Polyneuropathy) 01/2023 - 12/2005
11	Infections 05/2024 - 04/2005
9	Pain (Aches) 12/2023 - 10/2007
8	Disease Progression 01/2023 - 03/2002
6	Muscular Diseases (Myopathy) 03/2023 - 06/2003
5	Miller Fisher Syndrome (Fisher Syndrome) 12/2023 - 10/2008
5	Fatigue 12/2023 - 03/2011
5	Autoimmune Diseases (Autoimmune Disease) 12/2015 - 06/2010
4	Muscle Weakness 01/2021 - 03/2002
4	Inflammation (Inflammations) 02/2017 - 02/2010
4	Respiratory Insufficiency (Respiratory Failure) 02/2017 - 06/2010
4	Hypertension (High Blood Pressure) 01/2017 - 02/2010
3	Breakthrough Infections 05/2024 - 06/2022
3	COVID-19 05/2023 - 05/2022
3	Neuralgia (Stump Neuralgia) 11/2021 - 01/2018
3	Sudden Infant Death (SID) 01/2021 - 06/2013
3	Diarrhea 03/2011 - 02/2008
2	Ataxia (Dyssynergia) 12/2023 - 01/2009
2	Polyradiculoneuropathy (Polyradiculoneuritis) 01/2023 - 06/2010
2	Peripheral Nervous System Diseases (PNS Diseases) 01/2018 - 03/2014
2	Diabetes Mellitus 01/2016 - 06/2007
2	Monoclonal Gammopathy of Undetermined Significance 12/2015 - 09/2015
2	Neuromuscular Diseases (Neuromuscular Disease) 12/2015 - 06/2010
1	Nervous System Diseases (Neurological Disorders) 03/2024
1	Dermatitis 01/2023
1	AIDS-Related Complex (ARC) 06/2022
1	Demyelinating Diseases (Demyelinating Disease) 01/2022
1	Epstein-Barr Virus Infections 01/2021
1	Multiple Sclerosis 01/2021
1	Painful Neuropathy 01/2018
1	Multiple Myeloma 01/2018

Drug/Important Bio-Agent (IBA)

39	Intravenous Immunoglobulins (IVIG)FDA Link 12/2023 - 06/2005
18	AntibodiesIBA 05/2024 - 04/2003
13	GangliosidesIBA 12/2023 - 04/2003
13	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2023 - 05/2009
12	Immunoglobulin G (IgG)IBA 12/2023 - 05/2005
9	Immunosuppressive Agents (Immunosuppressants)IBA 05/2024 - 11/2010
7	AcidsIBA 01/2023 - 08/2005
7	Immunoglobulins (Immunoglobulin)IBA 11/2021 - 11/2010
6	Biomarkers (Surrogate Marker)IBA 03/2024 - 06/2011
5	GlycogenIBA 01/2023 - 08/2007
5	alpha-Glucosidases (Acid Maltase)IBA 01/2023 - 06/2003
5	Methotrexate (Mexate)FDA LinkGeneric 01/2017 - 03/2002
4	Proteins (Proteins, Gene)FDA Link 12/2023 - 05/2009
4	Immunomodulating AgentsIBA 05/2023 - 11/2010
4	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 06/2007
4	AntigensIBA 12/2022 - 04/2003
4	human GAA protein (Myozyme)FDA Link 01/2022 - 12/2010
4	Amantadine (Aman)FDA LinkGeneric 01/2021 - 03/2011
4	Mycophenolic Acid (Cellcept)FDA LinkGeneric 01/2017 - 05/2009
4	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2017 - 05/2009
4	Rituximab (Mabthera)FDA Link 01/2017 - 05/2009
4	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2017 - 05/2009
4	Azathioprine (Imuran)FDA LinkGeneric 01/2017 - 05/2009
4	GlucosidasesIBA 11/2013 - 12/2010
3	EnzymesIBA 01/2023 - 08/2007
3	InterferonsIBA 01/2017 - 05/2009
3	Insulin (Novolin)FDA Link 10/2016 - 02/2010
3	Immunoglobulin M (IgM)IBA 12/2015 - 12/2005
3	CaprylatesIBA 02/2012 - 02/2008
2	Tricyclic Antidepressive Agents (Tricyclic Antidepressants)IBA 12/2023 - 12/2023
2	Carbamazepine (Tegretol)FDA LinkGeneric 12/2023 - 12/2023
2	Methylprednisolone FDA LinkGeneric 01/2022 - 10/2007
2	Interferon beta-1a FDA Link 01/2017 - 06/2013
2	Creatine Kinase (Creatine Phosphokinase)IBA 02/2016 - 03/2002
2	Interferon-betaIBA 06/2013 - 11/2010
2	Interferon-alpha (Interferon Alfa)IBA 06/2013 - 11/2010
2	Indicators and Reagents (Reagents)IBA 03/2011 - 06/2010
2	IceIBA 09/2010 - 02/2008
2	OligosaccharidesIBA 07/2010 - 02/2008
1	GlycosphingolipidsIBA 01/2023
1	1,4-alpha-Glucan Branching Enzyme (Glycogen Branching Enzyme)IBA 01/2023
1	Glycogen Synthase (Synthase I)IBA 01/2023
1	UTP-Glucose-1-Phosphate Uridylyltransferase (UDP Glucose Pyrophosphorylase)IBA 01/2023
1	G(M1) GangliosideIBA 01/2023
1	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 01/2023
1	antineoplaston A10 (A 10)IBA 01/2023
1	glycogeninIBA 01/2023
1	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 01/2022
1	Complement System Proteins (Complement)IBA 01/2022
1	Natalizumab (Tysabri)FDA Link 01/2021
1	N 30IBA 01/2020
1	Alemtuzumab (Campath)FDA Link 01/2020
1	SaltsIBA 12/2019
1	Bortezomib (Velcade)FDA Link 01/2018
1	PanzygaIBA 01/2018

Therapy/Procedure

19	Enzyme Replacement Therapy 03/2023 - 06/2003
10	Plasma Exchange 11/2021 - 06/2005
9	Therapeutics 01/2022 - 06/2005
5	Artificial Respiration (Mechanical Ventilation) 02/2017 - 06/2010
3	Immunotherapy 01/2021 - 02/2004
3	Aftercare (After-Treatment) 02/2017 - 03/2014
3	Mechanical Ventilators (Ventilator) 05/2015 - 08/2011
2	Enzyme Therapy 11/2019 - 09/2012
2	Activities of Daily Living (ADL) 07/2017 - 03/2015
1	Transjugular Intrahepatic Portasystemic Shunt 12/2022
1	Drug Tapering 01/2018